9 Best Psychedelic Stocks to Buy in 2026
The AdvisorShares Psychedelics ETF, a fund that primarily invests in the psychedelic drugs sector, is up 31% over the past year. That almost doubles the S&P 500’s 16% gain over the same timeframe.
Abbvie Inc. (ABBV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,033,800 | $464,702,962 | -16% | 0.07% | |
| 2. | GLG Partners Noam Gottesman | 1,808,707 | $413,271,463 | +41% | 0.7% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 1,508,715 | $344,726,290 | -19% | 0.52% |
| 4. | 1,432,800 | $327,380,472 | -25% | 0.05% | |
| 5. | AQR Capital Management Cliff Asness | 1,150,746 | $262,933,724 | +25% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | $106,950.00 | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | $54,000.00 | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | $150,004.80 | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $233.56 | 5,230 | $1,221,518.80 | 2,654 | 2026-03-04 | Filing | |
| $235.26 | 2,600 | $611,676.00 | 4,619 | 2026-03-02 | Filing | |
| $234.66 | 10,291 | $2,414,886.06 | 7,219 | 2026-03-02 | Filing | |
| $233.51 | 5,777 | $1,348,987.27 | 17,510 | 2026-03-02 | Filing | |
| $230.00 | 22,381 | $5,147,630.00 | 38,137 | 2026-02-25 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 62,853 | $13,670,007 | 0.64% | |
| 2. | 49,604 | $10,788,374 | 1.07% | |
| 3. | 43,066 | $9,366,637 | 1.9% | |
| 4. | 29,797 | $6,480,591 | 0.22% | |
| 5. | 24,892 | $5,413,703 | 0.44% |
News See All
15 Dividend Stocks to Buy for Steady Income
Equity income is getting harder to find. The Morningstar US Market Index had a dividend yield of under 1.2% in the first quarter of 2026. By historical standards, that is quite low.
AbbVie Inc. (ABBV): Billionaire Ken Fisher Admires This Pharma Stock
AbbVie Inc. (NYSE:ABBV) is a constant part of the 13F portfolio of Fisher Asset Management since the start of 2013.
William Blair Asserts AbbVie Inc. (ABBV) Growth Prospects on Obesity Treatment Opportunities
AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs top healthcare stocks. On March 9, William Blair reiterated an Outperform rating on AbbVie Inc. (NYSE:ABBV).
Billionaire Ken Fisher's 15 Most Notable Moves for 2026
For many Wall Street investors, it is their first time navigating market uncertainty at a time of geopolitical upheaval.
Is AbbVie Inc. (ABBV) A Good Stock to Buy Now?
Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ABBV.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?
AbbVie Inc. (NYSE:ABBV) is one of the debt free halal stocks to buy. On March 3, at the TD Cowen 46th Annual Health Care Conference, AbbVie Inc.
11 Debt Free Halal Stocks to Buy
Jitters in the US equity market are rising as concerns about artificial intelligence, a looming software-as-a-service downturn, and ongoing conflict in the Middle East unsettled investors.
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages
On February 24, RBC Capital began coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a price target of $260.
Hedge Fund Resource Center